Patent: 10,272,142
✉ Email this page to a colleague
Summary for Patent: 10,272,142
Title: | Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders |
Abstract: | Compositions and methods useful for the treatment of neuromyelitis optica (NMO) or neuromyelitis optica spectrum disorder (NMOSD) are disclosed. |
Inventor(s): | Broom; Colin (Devon, PA), Dayno; Jeffrey (Maple Glen, PA) |
Assignee: | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) |
Application Number: | 14/539,405 |
Patent Claims: | see list of patent claims |
Details for Patent 10,272,142
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2039-05-17 |
Alexion Pharmaceuticals, Inc. | SOLIRIS | eculizumab | Injection | 125166 | 03/16/2007 | ⤷ Try a Trial | 2039-05-17 |
Genentech, Inc. | RITUXAN HYCELA | rituximab and hyaluronidase human | Injection | 761064 | 06/22/2017 | ⤷ Try a Trial | 2039-05-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |